Elevated Troponin I in patients with no or non-obstructive coronary arterial disease; Characterization by Cardiac MRI by Bharat Singh et al.
BioMed Central
Journal of Cardiovascular Magnetic 
Resonance
ssOpen AccePoster presentation
Elevated Troponin I in patients with no or non-obstructive coronary 
arterial disease; Characterization by Cardiac MRI
Bharat Singh*, Anthon R Fuisz and Gaby Weissman
Address: Washington Hospital Center, Washington, DC, USA
* Corresponding author    
Introduction
Patients with elevated Troponin I (Tn-I) are frequently
referred for cardiac catheterization, but the absence of
obstructive coronary arterial disease leads to diagnostic
questions. Cardiac MRI (cMRI) is a powerful tool for char-
acterizing myocardial abnormalities, and the use of con-
trast-enhanced techniques can determine the underlying
pathology.
Purpose
cMRI can define the etiology of elevated Tn-I in patients
with non-obstructive disease, and may help define prog-
nosis.
Methods
All patients with non-obstructive CAD by coronary angi-
ography (<50% luminal stenosis) and an elevated Tn-I
who were referred for contrast-enhanced cMRI were retro-
spectively identified for the period of 11/29/2004-6/28/
2008. Patients were subdivided based on cMRI findings:
1)Normal, 2)Ischemic Disease, 3)Myocarditis, 4)Tako-
tsubo, and 5)Non-Ischemic Cardiomyopathy (NICM).
Clinical characteristics (age, sex), Tn-I level, and ejection
fraction (EF) were reviewed, as well as survival using the
social security death index.
Results
53 patients met the inclusion criteria. Twenty had normal
angiograms, 33 had non-obstructive disease. Six (11%)
had Normal cMRI parameters, 12(23%) had Ischemic dis-
ease, 12(23%) Myocarditis, 14(26%) Tako-Tsubo, and
9(17%) NICM. There was no significant difference in age
(standard deviation (SD) in parentheses) 44.4(14.7),
56.1(7.5), 49.2(18.5), 57.0(11.8), and 54.4(15.1) respec-
tively and Tn-I, 3.6(2.5), 26.2(48.1), 11.7(17.3), 2.6(2.1),
and 2.5(2.5). The EF did vary in the groups (p < 0.05),
67.5(10.5), 59.8(14.2), 51.0(15.3), 50.6(10.8), and
39.1(8.8) respectively. Patients were followed up for 2.1 ±
1.0 years. There were 6 deaths [3 in the NICM group, 2 in
myocarditis, and 1 in the normal group (P = 0.16)], Table
1.
Conclusion
Contrast enhanced cMRI is a useful modality in differen-
tiating the conditions causing elevated Troponin I in set-
ting of a non-obstructive coronary angiogram. Further
follow-up is needed to ascertain the prognostic signifi-
cance of cMRI findings.
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Normal Infarct Myocarditis Tako-Tsubo NICM
N (%) 6(11) 12(23) 12(23) 14(26) 9(17)
Age in yrs(SD) 44.4 (14.7) 56.1 (7.5) 49.2 (18.5) 57.0 (11.8) 54.4(15.1)
Males (%) 3(50) 1(8) 7(58) 2(13) 4(44)
EF% (SD) 67.5 (10.5) 59.8 (14.2) 51.0(15.3) 50.6 (10.8) 39.1(8.8)
Deaths 1 0 2 0 3
Troponin ng/ml (SD) 3.6 (2.5) 26.2 (48.1) 11.7(17.3) 2.6 (2.1) 2.5(2.5)Page 2 of 2
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